BNMS Radiopharmacy Forum Nottingham Seminar

The BNMS Radiopharmacy Forum: Nottingham Seminar is a dedicated one-day event focusing on the rigorous standards and innovative breakthroughs in the production of radiopharmaceuticals. In the current regulatory climate, maintaining compliance with Good Manufacturing Practice (GMP) while integrating new isotopes into the clinical pipeline is a significant challenge for pharmacy departments across the UK. This seminar serves as a critical update for those working on the "front line" of isotope preparation.

The morning sessions are dedicated to regulatory updates, featuring guest speakers from the MHRA and seasoned radiopharmacists who have successfully navigated recent inspections. Discussion topics include the implementation of automated synthesis modules and the transition from manual dispensing to robotic systems to minimize radiation exposure to staff. As the industry moves toward more centralized production models, the seminar explores the logistics of "hub and spoke" distribution and the stability of short-lived isotopes during transport.

The afternoon transitions into a research-heavy focus, highlighting local Nottingham-based research into alpha-emitting isotopes. The potential of Actinium-225 and Lead-212 for targeted alpha therapy is a major highlight, with experts discussing the chemical challenges of stable chelation. Attendees will also participate in a roundtable discussion regarding the global supply chain issues affecting Molybdenum-99 and how UK centers can build resilience through domestic production initiatives. This seminar is more than just a series of lectures; it is a collaborative platform for radiopharmacists to share "lessons learned" and refine the protocols that ensure patient safety and product efficacy.